GABAA receptors: Subtypes, regional distribution, and function

Journal of Clinical Sleep Medicine

Volumn 2, Issue 2, 2006, Pages

  Nutt, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE;

CONFERENCE PAPER; DRUG TARGETING; GENETIC ENGINEERING; IN VIVO CULTURE; NONHUMAN; TRANSGENIC MOUSE; ANXIETY DISORDER; CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; REVIEW; SCINTISCANNING;

ANXIETY DISORDERS; BENZODIAZEPINES; HUMANS; IMMUNOHISTOCHEMISTRY; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA-A; STRESS DISORDERS, POST-TRAUMATIC;

EID: 33745122547     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci. 2000;21:16-9.
2. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179:390-6.
3. Jin H, Wu H, Osterhaus G et al. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci USA. 2003;100:4293-8.
4. Cherubini E, Conti F. Generating diversity at GABAergic synapses. Trends Neurosci. 2001;24:155-62.
5. Deken SL, Wang D, Quick MW. Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J Neurosci. 2003;23:1563-8.
6. Bowery NG, Hudson AL, Price GW. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience. 1987;20:365-83.
7. Ong J, Kerr DI. Recent advances in GABAB receptors: from pharmacology to molecular biology. Acta Pharmacol Sin. 2000;21:111-23.
8. Nayeem N, Green TP, Martin IL, Barnard EA. Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. J Neurochem. 1994;62:815-8.
9. Whiting PJ, Bonnert TP, McKernan RM et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci. 1999;868:645-53.
10. Smith GB, Olsen RW. Functional domains of GABAA receptors. Trends Pharmacol Sci. 1995;16:162-8.
11. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. 2003;8:445-50.
12. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience. 2000;101:815-50.
13. Wisden W, Laurie DJ, Monyer H, Seeburg PH. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. 1. Telencephalon, diencephalon, mesencephalon. J Neurosci. 1992;12:1040-62.
14. Fritschy JM, Benke D, Mertens S, Oertel WH, Bachi T, Mohler H. Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc Natl Acad Sci USA. 1992;89:6726-30.
15. Gao B, Fritschy JM, Benke D, Mohler H. Neuron-specific expression of GABAA-receptor subtypes: differential association of the alpha 1- and alpha 3-subunits with serotonergic and GABAergic neurons. Neuroscience. 1993;54:881-92.
16. Loup F, Weinmann O, Yonekawa Y, Aguzzi A, Wieser HG, Fritschy JM. A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain. J Histochem Cytochem. 1998;46:1129-39.
17. Nusser Z, Sieghart W, Benke D, Fritschy JM, Somogyi P. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells. Proc Natl Acad Sci USA. 1996;93:11939-44.
18. Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693-703.
19. Brickley SG, Cull-Candy SG, Farrant M. Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol. 1996;497 (Pt 3):753-9.
20. Kullmann DM, Ruiz A, Rusakov DM, Scott R, Semyanov A, Walker MC. Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog Biophys Mol Biol. 2005;87:33-46.
21. Rudolph U, Crestani F, Benke D et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature. 1999;401:796-800.
22. McKernan RM, Rosahl TW, Reynolds DS et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci. 2000;3:587-92.
23. Blednov YA, Jung S, Alva H et al. Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs. J Pharmacol Exp Ther. 2003;304:30-6.
24. Low K, Crestani F, Keist R et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290:131-4.
25. Chandra D, Korpi ER, Miralles CP, De Bias AL, Homanics GE. GABAA receptor gamma2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. BMC Neurosci. 2005;6:30.
26. Kralic JE, Wheeler M, Renzi K et al. Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther. 2003;305:600-7.
27. Jurd R, Arras M, Lambert S et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J. 2003;17:250-2.
28. Liao M, Sonner JM, Jurd R et al. Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg. 2005;101:412-8, table.
29. Homanics GE, Ferguson C, Quinlan JJ et al. Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol. 1997;51:588-96.
30. Mihalek RM, Banerjee PK, Korpi ER et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA. 1999;96:12905-10.
31. Homanics GE, Delorey TM, Firestone LL et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA. 1997;94:4143-8.
32. Collinson N, Kuenzi FM, Jarolimek W et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci. 2002;22:5572-80.
33. Crestani F, Keist R, Fritschy JM et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA. 2002;99:8980-5.
34. Burgess N, Maguire EA, O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron. 2002;35:625-41.
35. Wiltgen BJ, Sanders MJ, Ferguson C, Homanics GE, Fanselow MS. Trace fear conditioning is enhanced in mice lacking the delta subunit of the GABAA receptor. Learn Mem. 2005;12:327-33.
36. Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry. 1998;55:715-20.
37. Tiihonen J, Kuikka J, Rasanen P et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry. 1997;2:463-71.
38. Bremner JD, Innis RB, Southwick SM, Staib L, Zoghbi S, Charney DS. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry. 2000;157:1120-6.
39. Lingford-Hughes A, Hume SP, Feeney A et al. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography. J Cereb Blood Flow Metab. 2002;22:878-89.
40. Krogsgaard-Larsen P, Frolund B, Liljefors T, Ebert B. GABA(A) agonists and partial agonists: TRIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem Pharmacol. 2004;68:1573-80.
41. Chambers MS, Atack JR, Broughton HB et al. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition. J Med Chem. 2003;46:2227-40.
42. Chambers MS, Atack JR, Carling RW et al. An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. J Med Chem. 2004;47:5829-32.